Andre Cabral-Sarmento
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Intermittent Time-Restricted Feeding Recapitulates the Physiological Benefits of Daily Time-Restricted Feeding in Male Mice with Chronic Metabolic Disease.
Journal: Molecular metabolism
Published: July 16, 2026
Emerging insights into the pathophysiology of pituitary tumour microenvironment.
Journal: Endocrine-related cancer
Published: May 22, 2026
Environmental Modulation of Physiological Parameters in the Paediatric Intensive Care Unit After Extracorporeal Cardiac Surgery.
Journal: Nursing in critical care
Published: March 19, 2026
Metformin improves hepatic steatosis in diet induced obese FVB/N mice: Alterations of glucose metabolism and hepatic splicing machinery.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 11, 2025
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2.
Journal: Cell communication and signaling : CCS
Published: September 12, 2025
miR-191-5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 01, 2025
From pituitary cells to prostate gland in health and disease: direct and indirect endocrine connections.
Journal: Reviews in endocrine & metabolic disorders
Published: January 27, 2025
Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer.
Journal: International journal of molecular sciences
Published: December 28, 2024
Interaction between clock genes, melatonin and cardiovascular outcomes from ICU patients.
Journal: Intensive care medicine experimental
Published: November 14, 2024
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.
Journal: Molecular therapy. Oncology
Published: October 19, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.
Journal: Science advances
Published: October 02, 2024
Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?
Journal: International journal of molecular sciences
Published: November 29, 2023
Last Updated: 09/26/2026